Form preview

Get the free ARANESP/EPOGEN/PROCRIT PRIOR APPROVAL REQUEST

Get Form
This document is a prior approval request form for the drugs ARANESP, EPOGEN, and PROCRIT, requiring completion by both the cardholder and the prescribing physician to process claims for prescription
We are not affiliated with any brand or entity on this form

Get, Create, Make and Sign aranespepogenprocrit prior approval request

Edit
Edit your aranespepogenprocrit prior approval request form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your aranespepogenprocrit prior approval request form via URL. You can also download, print, or export forms to your preferred cloud storage service.

How to edit aranespepogenprocrit prior approval request online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
To use our professional PDF editor, follow these steps:
1
Log in. Click Start Free Trial and create a profile if necessary.
2
Prepare a file. Use the Add New button to start a new project. Then, using your device, upload your file to the system by importing it from internal mail, the cloud, or adding its URL.
3
Edit aranespepogenprocrit prior approval request. Replace text, adding objects, rearranging pages, and more. Then select the Documents tab to combine, divide, lock or unlock the file.
4
Save your file. Select it from your list of records. Then, move your cursor to the right toolbar and choose one of the exporting options. You can save it in multiple formats, download it as a PDF, send it by email, or store it in the cloud, among other things.
With pdfFiller, it's always easy to deal with documents.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out aranespepogenprocrit prior approval request

Illustration

How to fill out ARANESP/EPOGEN/PROCRIT PRIOR APPROVAL REQUEST

01
Obtain the ARANESP/EPOGEN/PROCRIT Prior Approval Request form from your healthcare provider or insurance company.
02
Fill in the patient's personal information, including name, date of birth, and insurance details.
03
Provide the patient's medical history relevant to the use of ARANESP/EPOGEN/PROCRIT.
04
Include the diagnosis for which the medication is being requested.
05
Document previous treatments and their outcomes, if relevant.
06
Specify the prescribed dosage and frequency of the medication.
07
Attach any supporting medical records or laboratory results that justify the need for the medication.
08
Review the completed form for accuracy and completeness before submission.
09
Submit the form to the insurance company along with any required additional documentation.
10
Follow up with the insurance company to confirm receipt and approval status.

Who needs ARANESP/EPOGEN/PROCRIT PRIOR APPROVAL REQUEST?

01
Patients diagnosed with anemia due to chronic kidney disease.
02
Cancer patients undergoing chemotherapy who experience anemia.
03
Patients with anemia due to HIV infection or other chronic diseases.
04
Individuals who have not responded adequately to other forms of anemia treatment.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.0
Satisfied
47 Votes

People Also Ask about

Initiate PROCRIT treatment only when the hemoglobin level is less than 10 g/dL. If the hemoglobin level approaches or exceeds 12 g/dL, reduce or interrupt the dose of PROCRIT. The recommended starting dose for pediatric patients (ages 1 month or older) is 50 Units/kg 3 times weekly intravenously or subcutaneously.
APPROVAL CRITERIA Individual has a baseline hemoglobin (Hgb) level are less than 10 g/dL; AND II. Baseline iron status is adequate as defined by one of the following: A. Transferrin saturation 20% or greater; OR B. Ferritin 80ng/mL or greater; OR C.
Following blood tests, your doctor will prescribe the strength of that is best for you. can be self-administered by injection under the skin after training from your doctor or nurse. It can also be injected into a vein by a doctor or nurse.
/Procrit was approved on June 1, 1989 for the treatment of anemia associated with chronic renal failure, including patients on dialysis and patients not on dialysis and on April 1, 1993 for the treatment of anemia due to the effects of concomitant myelosuppressive chemotherapy.
is indicated for the treatment of anemia in patients with non-myeloid malignancies where anemia is due to the effect of concomitant myelosuppressive chemotherapy, and upon initiation, there is a minimum of two additional months of planned chemotherapy.
Considerations Correct or exclude other causes of anemia before initiating ® Evaluate the iron status of all patients before and during treatment. Administer supplemental iron therapy if serum ferritin is < 100 mcg/L or serum transferrin saturation is < 20%.
It is given every 1 to 4 weeks depending on the condition being treated and as prescribed by your doctor. You may need frequent medical tests to be sure that there are no harmful effects from the use of . Your injections may be delayed based on the results of these tests.
alfa (Retacrit, Procrit, ) is a glycoprotein that stimulates red blood cell production, whereas, alfa () stimulates erythropoiesis by the same mechanism as endogenous erythropoietin.

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

ARANESP/EPOGEN/PROCRIT PRIOR APPROVAL REQUEST is a formal submission that healthcare providers must complete to obtain authorization from insurance companies or government programs for the use of erythropoiesis-stimulating agents like ARANESP, EPOGEN, or PROCRIT in treating specific conditions such as anemia.
Healthcare providers, such as doctors and clinics, who prescribe ARANESP, EPOGEN, or PROCRIT for patients must file this request to ensure coverage from insurance providers.
To fill out the request, providers must provide patient information, diagnosis codes, treatment history, reason for use, and necessary supporting documentation as required by the insurance provider.
The purpose is to ensure that the prescribed treatment using ARANESP, EPOGEN, or PROCRIT is medically necessary and meets the criteria set by the payer for reimbursement.
The information required includes patient demographic details, medical history, prescribed dosage, frequency of administration, diagnosis, previous treatments, and justification for the use of the medication.
Fill out your aranespepogenprocrit prior approval request online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.